Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,017 public trials 1,024 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Active, Not Recruiting

A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer

NCT04577833

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • START Mountain Region West Valley City, Utah, United States
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • GZA Ziekenhuizen- Campus St Augustinus Wilrijk, Belgium
  • Institut Bergonié, Centre de Lutte Contre le Cancer Bordeaux, France
View all 16 locations
View Trial Details
Active, Not Recruiting

A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer

NCT04557059

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Arizona Urology Specialists Tucson, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Colorado Clinical Research Lakewood, Colorado, United States
  • Urological Research Network Hialeah, Florida, United States
View all 141 locations
View Trial Details
Active, Not Recruiting

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer

NCT04662580

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California, Los Angeles School of Medicine Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer

NCT04898634

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Columbia University Medical Center Herbert Irving Pavilion New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Washington Seattle, Washington, United States
  • Peking University Third Hospital Beijing, China
View all 17 locations
View Trial Details
Active, Not Recruiting

An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

NCT02531516

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Homewood, Alabama, United States
  • Chandler, Arizona, United States
  • Scottsdale, Arizona, United States
  • Tucson, Arizona, United States
View all 263 locations
View Trial Details
Active, Not Recruiting

A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

NCT04644770

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +11 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details

Related conditions